Malarial <scp>PI4K</scp> inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition-Reference-Cited by-同舟云学术

Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition

Published:2022-04-13 Issue:10 Volume:114 Page:487-498
ISSN:2472-1727
Container-title:Birth Defects Research
language:en
Short-container-title:Birth Defects Research

Author:

Demarta‐Gatsi Claudia¹^ORCID,Donini Cristina¹,Duffy James¹,Sadler Claire²,Stewart Jane²,Barber Jane A.²,Tornesi Belen¹

Affiliation:

1. Translational Medicine department Medicines for Malaria Venture Geneva Switzerland

2. ApconiX Macclesfield UK

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Developmental Biology,Toxicology,Embryology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdr2.2012

Reference34 articles.

1. Incidence of congenital diaphragmatic hernia in the young of rats bred on a diet deficient in vitamin A;Anderson D. H.;American Journal of Diseases of Children,1941

2. Embryological origins and development of the rat diaphragm

3. Phosphatidylinositol 4-kinases: Function, structure, and inhibition

4. New developments in anti-malarial target candidate and product profiles

5. The Activation of the Retinoic Acid Response Element Is Inhibited in an Animal Model of Congenital Diaphragmatic Hernia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria;Antimicrobial Agents and Chemotherapy;2024-08-28

2. 2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy;Journal of Medicinal Chemistry;2024-06-25

3. Research progress on phosphatidylinositol 4-kinase inhibitors;Biochemical Pharmacology;2024-02

4. RECENT ADVANCES, CHALLENGES AND UPDATES ON THE DEVELOPMENT OF THERAPEUTICS FOR MALARIA;EXCLI J;2024

5. Developing kinase inhibitors for malaria: an opportunity or liability?;Trends in Parasitology;2023-09